Takeda Announces Appointment of New Senior Leadership

September 30, 2014

Osaka, Japan, September 30, 2014 --- Takeda Pharmaceutical Company Limited today announced the new appointment of senior leadership. The details are as follows:

･ New appointment of the Corporate Officers effective October 1, 2014:

Assignment	Name
Global General Counsel	Yoshihiro Nakagawa
President, Global Oncology Business Unit	Christophe Bianchi
President, Global Vaccine Business Unit	Rajeev Venkayya
President, Emerging Markets Business Unit	Giles Platford
Global Manufacturing and Supply Officer	Thomas Wozniewski
Global Quality Officer	Gerard Greco
Global Compliance Officer	Mwana Lugogo

･ New senior leadership effective October 1, 2014:

New assignment	Previous assignment	Name
Corporate Officer, Corporate Communications & Public Affairs Officer, Senior Vice President, Corporate Communications Department	(Corporate Officer, Senior Vice President, Head of North Asia)	Haruhiko Hirate

###